SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Bristol-Myers Squibb Company Release: New Four- and Five-Year Survival Data for YERVOY® (ipilimumab) in Treatment-Naïve and Previously-Treated Metastatic Melanoma Presented at the ESMO 2012 Congress (European Society for Medical Oncology)